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INTRODUCTION
The birth  process  is  described as  the most  perilious journey an individual  ever  undertakes. 
Meconium staining of the amniotic fluid and abnormalities in the fetal heart rate pattern have long been 
recognized as danger signals in this journey.
J. Whitridge Williams (1903) observed that “characteristic sign of impending asphyxia is the 
escape of meconium”. There are two principal reasons why meconium is passed by the fetus-maturity 
and fetal  compromise.  Meconium passage  reflects  maturity  of  the  central  nervous  system and the 
gastrointestinal tract. Incidence of meconium stained liquor increases steadily from 10% at 36 weeks to 
30% at 40 weeks and 50% at 42 weeks. Fetal compromise of an acute or subacute nature also leads to 
passage of meconium. Whatever be the controversies regarding meconium, the following holds true:
1. Clear amniotic fluid is reassuring.
2. Thick fresh meconium in a situation of high risk is of great concern.
Presence of abnormal fetal heart rate pattern in the presence of meconium stained amniotic fluid 
is a definite indication of fetal compromise.
AIM OF THE STUDY
This prospective study aims :
1. To evaluate the perinatal outcome in term pregnancies with meconium stained amniotic fluid.
2. To bring out the correlation between fetal heart rate abnormalities and perinatal outcome in 
meconium stained amniotic fluid.
REVIEW OF LITERATURE
“The birth of a healthy baby is the universal aim”.
HISTORICAL PROSPECTIVE:
Meconium is a term derived from the Greek word ‘Mekonion’, a word for ‘poppy juice’ or 
‘opium  like’.  Aristotle  is  credited  with  having  drawn  the  analogy  between  the  presence  of  this 
substance in the amniotic fluid and the “sleepy” newborn.
Laennec (1806), a physician in Paris was the father of technique of auscultation of adult heart 
and lungs.
Schwartz  and Von  Winckel  (1858) stressed  the  importance  of  fetal  heart  rate  auscultation 
throughout labour. He thought the appearance of meconium in labour meant impending fetal death.
In 1925, Schulze conducted a study of 5500 births in California and concluded that passage of 
meconium during  labour  is  in  the  large  majority of  cases  independent  of   fetal  asphyxia  and the 
presence  of  old  meconium  in  the  amniotic  fluid  was  of  no  prognostic  significance  for  the  later 
development of asphyxia. She has also observed that in cases associated with asphyxia, there were 
always changes of the fetal heart rate pattern during labour.
In  1958, Caldeyro Barcia, Hon and Hammacher reported their observation on various fetal 
heart rate patterns associated with fetal distress.
Ferton and Steer (1962) suggested that passage of meconium was significant only if fetal heart 
rate was less than 110 bpm.
In  1966, Saling introduced amnioscopy for pregnancies more than 10 days past the expected 
date of confinement and suggested that the finding of meconium indicates impending  danger and 
immediate amniotomy and fetal blood sampling should be performed. He postulated that fetal hypoxia 
precipitates  fetal  gut  vasoconstriction  which  causes  hyperperistalisis  and  sphincter  relaxation  with 
passage of meconium.
Brandes et al, (1973) observed that fetuses who have passed meconium during labour are in a 
state of temporary compensated fetal distress and should be delivered within a reasonable time.
Miller  et.  al.,  (1975) found  no  difference  in  neonatal  Apgar  between  meconium and non-
meconium group  if  the  fetal  heart  rate  during  labour  had  been  normal.  They concluded  that  the 
presence of meconium in the absence of other signs was not a sign of fetal distress.
Meis PJ; Hall. M(1978) observed that thin meconium stained amniotic fluid was not found to 
be associated with any increased intrapartum or neonatal morbidity or mortality in contrast to thick 
meconium stained amniotic fluid.
Starks et al., (1980) found that thick meconium was associated with lower fetal scalp blood pH 
than thin or absent meconium and concluded that thick meconium usually indicates fetal hypoxia or 
acidosis regardless of abnormal fetal heart rate. However more recent studies have established that 
infants with normal heart rate patterns have similar outcome whether or not meconium is present in the 
amniotic fluid.
Krebs and Coworkers  (1980) concluded that  bradycardia  and deceleration  are  significantly 
increased  in  patients  with  meconium stained  liquor.  He  devised  an  intrapartum cardiotocographic 
scoring system.
Benacerraf et. al., (1984) reported that the detection of thick meconium by ultrasonography, 
but further studies showed that vernix can produce a similar picture.
Grant et al., (1989) concluded that using a low 5 minute APGAR score as endpoint (APGAR < 
7)  abnormal  fetal  heart  rate  has  a  high negative predictive value  of  over  90% but  a  low positive 
predictive value of 30%. This means that normal trace indicates a fetus is not hypoxic but abnormal 
trace is associated with large number of false positives.
Steer PJ, Eigbe F, Lissauer TJ, Beard RW (1989) conducted a large study on 1219 patients 
with meconium stained amniotic fluid monitored by cardiotocography and sensitivity was 80% at any 
time for acidosis and predictive value was 32%.
Lately, studies on Urinary Meconium Index (UMI) by spectrophotometry have been reported. 
The entry of meconium into the maternal circulation occurs during labour pains and may be excreted in 
the  mother’s  urine.  The  entry takes  place  even in  the  absence  of  any clinical  signs  of  rupture  of 
membranes.  Patient who delivered babies with low Apgar had higher positive UMI of rising type. 
(Chinese Journal of obstetrics of Gynaecology 1990).
In  1993 Steer PJ and  Smith R studied the continuous monitoring of meconium in liquor by 
optical sensor mounted to an intrauterine probe.
SIGNIFICANCE OF AMNIOTIC FLUID MECONIUM
Meconium is a viscous green liquid that consists of GIT secretions, bile, bile acids, mucus, 
pancreatic juice, cellular debris, amniotic fluid, swallowed vernix caseosa, lanugo hair and squamous 
cells. It is rarely seen in the amniotic fluid until mid to late 3rd trimester. The incidence of meconium 
staining of the amniotic fluid is approximately 10% of all pregnancies. In 35% of these meconium is 
aspirated into the fetal lung and 10-40% of the asphyxiated babies who aspirate die neonatally.
FORMATION OF MECONIUM:
The gastrointestinal tract originates from both endoderm and splanchnic mesoderm by day 14 
after fertilization and is lined by undifferentiated cuboidal cells by day 18 (Arey, 1974; Grand et al.,  
1976). Intestinal villi appear by 7 weeks and active absorption of glucose and aminoacids occurs at 10 
weeks and 12 weeks respectively. By 12 weeks gestation, development of Meissner’s and Auerbach’s 
plexuses within the intestinal wall coincides with onset of peristalisis of the small intestine and colon. 
Meconium appears in the fetal intestine at approximately 70-85 days gestation  (Smith, 1976). High 
concentrations of intestinal  enzymes are present  in amniotic  fluid early in  gestation followed by a 
decline that could be related to increased anal sphincter tone (Potier et al., 1978 and Mulivor et. al.,  
1979).
Composition of meconium:
Colour : Dark green.
Physical properties : Thick, viscous and odourless.
Dry weight : 28%
Protein : No demonstrable amount.
Carbohydrate : 80%.
Lipid : Minimal.
Blood group substances : Present.
Nitrogen : High
pH : 5.5 to 7
Electrolytes : Na, K, Ca, Mg, Cu, Zn,
Water : 72 – 80%
Meconium  also  contains  bile  acids  and  salts,  enzymes,  amniotic  fluid,  swallowed  vernix 
caseosa, lanugo hair and squamous cells. Large concentrations of bile pigments excreted by the biliary 
tract from the fourth month onward give meconium its green colour. The fetus lacks intestinal bacteria, 
which accounts for many of the differences in composition between meconium and adult stool.
Theories of meconium passage :
 Maturation theory: 
Because meconium seldom is observed preterm  (Scott et al., 2001), its presence in amniotic 
fluid could reflect  gastrointestinal  maturity in late gestation.  (Matthews and Warshaw, 1979).  The 
hormonal control of fetal meconium passage is maturation dependent. Motilin, an intestinal peptide 
responsible for bowel persistalisis and defecation is high in the umbilical cord of term infants who have 
passed meconium compared to preterm with clear liquor.
The  neural  control  of  meconium  passage  is  also  dependent  on  gestational  age  because 
maturation and myelination of  gastrointestinal  tract  progresses  throughout  gestation.  Immaturity of 
intrinsic and extrinsic innervation of the bowel would impair the ability of premature fetus to pass 
meconium into the amniotic fluid. At autopsy, preterm neonates have more unmyelinated nerve trunks 
and fewer ganglion cells in distal colon compared with term neonates.
Transit time through fetal small intestine decreases as gestation advances. Further more as the 
fetus  matures,  the  intestinal  tract,  becomes  more  responsive  to  sympathomimetic  agents. 
Parasympathetic stimuli  initiate meconium passage after maturation of fetal intestinal tract after 34 
weeks.  The  incidence  of  meconium passage  during  labour  increases  with  the  gestational  age  and 
reaches approximately 30% at 40 weeks and 50% at 42 weeks.
Theory of fetal distress:
  The relationship of fetal hypoxia and intestinal persistalisis has been a consideration for many 
years.  Walker (1954), demonstrated that meconium was released more frequently when the oxygen 
saturation of the umbilical vein was below 30% and that heavy meconium is associated with lower 
oxygen saturation more often than light meconium. Hon (1963) suggested that meconium is passed in 
response to parasympathetic stimulation during cord compression, but  Krebs and  Associates (1980) 
found no difference in the frequency of variable decelerations regardless of whether meconium was 
present. Umbilical cord erythropoietin concentrations are elevated in human pregnancies complicated 
by  meconium  stained  amniotic  fluid,  suggesting  an  association  between  chronic  hypoxemia  and 
meconium passage  (Richey  et  al.,  1995;  Jazayeri  et  al.,  2000).  Manning and Coworkers  (1990) 
reported that amniotic fluid meconium was present more than twice as often if the last biophysical 
profile score was abnormal (6 or less). 
Fetal compromise usually of an acute or subacute nature leads to passage of meconium. There 
are various degrees of meconium staining from diluted old meconium which is brownish yellow to 
thick green “pea soup” meconium. Typically thick undiluted meconium seen in breech presentation is 
for obvious mechanical reason. Meconium passage in preterm infants can occur if it becomes infected 
with organisms which can cause a fetal  enteritis (Listeria monocytogenes,  ureaplasma urealyticum, 
rotavirus).
Thick meconium stained amniotic fluid is associated with increased peripartum infection rates. 
Some reports have suggested an increased risk of meconium passage in association with cholestasis of 
pregnancy.
ETIOLOGY OF MECONIUM PASSAGE
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MECONIUM PASSAGE
Meconium and fetal distress
Is meconium, a marker for fetal distress ?
Obstetric textbooks though the 17th, 18th and 19th centuries reported meconium passage as a sign 
of fetal death or impending death.
However it is not true to say “ no death without defecation”. As Miller et al., have stated, the 
presence of meconium in the amniotic fluid without signs of asphyxia is not a sign of fetal distress, and 
is not in itself, a cause for intervention. Katz and Bowes (1992) stated that “when normal FHR patterns 
are found with meconium stained amniotic fluid the neonatal outcome is similar to neonates with clear 
fluid. Similarly, in infants with meconium stained amniotic fluid with antepartum signs of distress – 
neonatal  outcomes  are  similar  to  those  of  non  –  meconium  stained  infants  with  similar  FHR 
abnormalities”. Perhaps the most important clinical value of meconium stained amniotic fluids is to 
alert the obstetrician, to look for further signs of fetal compromise.
Meconium aspiration syndrome (MAS)
The term “meconium aspiration” refers to the presence of meconium below the vocal cords and 
in the lungs. When amniotic fluid contains meconium, meconium is found below the vocal cords in 
approximately 1/3 of neonates, ranging from 21% to 56%. But meconium aspiration syndrome (MAS) 
develops in 2-8% of infants delivered through meconium stained amniotic fluids (Davies et al., 1985,  
Rossi et al., 1989).
 Aspiration of meconium was thought by many authors to occur at the time of delivery as the 
new born infant take its first breath. So, oropharyngeal suctioning and tracheal toileting have been 
widely promoted in order to prevent MAS. However, it now seems likely that meconium aspiration 
most commonly occurs in utero as it still occurs despite adequate suctioning at delivery.
Meconium aspiration occurs in utero due to fetal breathing movements, which are of two types 
– gasping and deep breathing. Gasping is the fetal response to hypoxia. The fetus may also inhale 
meconium by deep irregular breathing in utero not associated with hypoxia. These breaths become 
more frequent as gestation advances and comprises about 10% of all fetal breathing movements. Fetal 
hypercapnia and acidosis also increase these breathing movements.
Meconium aspiration is more common when the meconium is thick rather than thin, this may be 
due to reflection of the fact that  oligohydramnios  and therefore undiluted meconium is more likely to 
lead to fetal hypoxia due to cord compression and consequently increased breathing.
PATHOPHYSIOLOGY OF MAS:
It involves a combination of mechanical obstruction and chemical pneumonitis of small 
airway  by  particulate  meconium inhaled  at  the  time  of  infant’s  first  breath.  (Tyler  et  al.,  1978;  
Perlman et al., 1989)
PATHOPHYSIOLOGY OF MECONIUM ASPIRATION SYNDROME
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Resultant  pulmonary vascular  spasm then  would  lead  to  pulmonary hypertension  and right  to  left 
shunting  through the  patent  foramen ovale  or  ductus  arteriosus.  Worsening  hypoxia  could  lead  to 
convulsions,  renal  failure,  disseminated  intravascular  coagulation  and  heart  failure  (Brady  and 
Goldman,  1986).  Pulmonary  function  can  further  be  compromised  by  displacement  of  pulmonary 
surfactant by free fatty acids in meconium (Clark et al., 1987) or by direct inhibition of surfactant’s 
surface tension-reducing properties, by meconium (oh and Bae, 2000; Hertig et al., 2001).
CLINICAL FEATURES:
MAS is characterized by mild to severe respiratory distress at birth. Meconium inhaled in an 
infant (which has not been subjected to hypoxia) usually causes mild disease only and is asymptomatic 
in 90% of cases. In its mildest form, the disease could present with neonatal tachypnoea associated with 
normal  pH and low pCO2, resolving within 2-3 days.  In its  more severe form,  the syndrome can 
present with hypoxemia, acidosis and respiratory failure.
Hypoxia
Hypercapnea and 
Acidosis
CHEST X – RAY SHOWING MECONIUM ASPIRATION SYNDROME
MANAGEMENT  OF MECONIUM ASPIRATION
MECONIUM 
ASPIRATION
DIRECT LARYNGOSCOPY
No meconium on or near 
larynx and baby well
Meconium distal to vocal 
cords 
Suction to oropharynx 
posterior pharynx 
Intubate with largest tracheal tube 
possible  (usually 3 – 3.5mm)
Aspirate Meconium
With largest 
Possible catheter
Directly via 
the tube
If tube blocks
Reintubate continue to aspirate until 
meconioum is cleared
If condition deteriorates then start I.P.P.V. 
using 100% O2. Aspirate stomach
Transfer to NICU
Postnatal therapy for MAS begins with continuous observation and monitoring of infants at 
risk. Mechanical ventilation is required in upto 30% of infants with severe MAS and must be managed 
carefully. Continuous positive airway pressure or PEEP may aggravate hyperinflation associated with 
MAS  and  should  be  used  with  caution.  The  sickest  neonates  could  even  require  extracorporeal 
membrane  oxygenation  (ECMO)  to  maintain  oxygenation  and  prevent  barotrauma  until  alveolar 
healing occurs and pulmonary function improves enough to meet baseline oxygen demands.
Pneumothorax or pneumomediastinum occurs frequently during the course of MAS because of 
the  ball-valve  effect  of  meconium  and  may  occur  before  the  application  of  positive-pressure 
ventilation. Therapy of the infant with MAS includes careful observation and vigorous treatment of 
other sequelae of neonatal asphyxia including temperature instability,  hypoglycemia,  hypocalcemia, 
hypotension, decreased cardiac function, reduced renal function, reduced liver production of clotting 
factors, hypoalbuminemia, cerebral edema and seizures. The mortality rate from MAS is as high as 
40% in affected neonates.
PREVENTION OF MAS:
Is MAS preventable?
Pfenninger and Coworkers (1984) demonstrated that oropharnygeal suction is superior to nasal 
suctioning and although both methods should be used in succession.
Wiswell  and Colleagues (2000) found that  oropharyngeal  suctioning before delivery of  the 
thorax decreased the incidence of MAS, but there was no difference between bulb suctioning and De 
Lee suctioning.
Unfortunately,  even  the  most  vigorous  suctioning  before  the  first  breath  does  not  remove 
meconium already aspirated into the lungs before breath and thus does not eliminate the occurrence of 
MAS. Several authors have documented in utero meconium aspiration (Manning et al., 1978; Brown 
and Gleicher, 1981). The evidence supporting this contention comes from autopsy studies showing 
meconium in the alveolar spaces both in  stillborn infants and in newborns vigorously suctioned before 
the first breath. Thus, MAS is not always preventable, despite aggressive airway management at the 
time of delivery.
Katz and Bowes (1992) questioned whether meconium is necessary for a reported diagnosis of 
MAS. Mild MAS follow from the classic theory of meconium inhalation, but severe MAS appear to be 
multifactorial.
Thickness of meconium and abnormal FHR patterns have been associated with a higher risk of MAS. 
Rossi and Colleagues (1989) found that 19% of infants with thick meconium had MAS compared with 
5% of those with moderate and 3% of those with thin meconium.
Fleischer  and  Colleagues  (1992) reported  that  the  risk  of  neonatal  respiratory 
complications in the presence of meconium was 2% when FHR patterns were normal and 12% when 
they were abnormal.  Paz and Associates (2001) found similar associations between MAS and FHR 
abnormalities.
Cunningham and colleagues (1990) and  Yoder (1994) used routine oropharnygeal  De Lee 
suctioning of all infants with meconium in the amniotic fluid, but tracheal intubation only for depressed 
infants with moderate to thick meconium.
In a large randomized trial (n = 2094) Wiswell and colleagues (2000) demonstrated no benefit 
to intubation and tracheal suctioning in vigorous infants born through amniotic fluid stained by any 
thickness of meconium.
The American  Academy of  Pediatrics  (2000)  recommended early  oropharyngeal  suctioning 
(before delivery of the shoulders) of all infants in the presence of meconium and tracheal visualization 
and suctioning for neonates who are depressed or born through particulate meconium.
MECONIUM STAINING OF THE TISSUES:
The degree to which tissues stain when exposed to meconium depends on the following:
1. Meconium concentration.
2. Length of exposure.
3. The nature of the exposed tissue.
Vernix suspended in meconium stains yellow in 12-14 hrs. Newborn fingernails stain yellow in 4-6 hrs. 
(Desmond et al, 1956) Miller and associates (1985) exposed placentas in vitro to meconium in varying 
concentrations and durations of exposure. Within one hour, surface staining was observed. Pigment 
accumulation in macrophages within the placenta, occurs by 3 hours. Umbilical cord staining occurred 
at 1 hour with 5% meconium and at 15 minutes with 10% meconium.
Meconium  could  have  direct  vosoconstrictive  effects  on  the  umbilical  vein  that  result  in 
vasospasm and impaired fetal placental blood flow (Altshuler and Hyde, 1989). In addition, meconium 
present for more than 16 hours occasionally induces umbilical cord ulceration and vascular necrosis, 
potentially compromising fetal oxygenation (Altshuler et al, 1992). These effects are due to bile acids 
present in meconium. Meconium in pulmonary macrophages suggests antepartum in utero aspiration. 
This information can be important postpartum in determining how long meconium has been present, 
especially in cases of meconium aspiration.
MECONIUM STAINED PLACENTA

AMNIOINFUSION
Amnioinfusion has been proposed as a way of diluting meconium and possibly decreasing the 
incidence of intrapartum MAS. It  not only helps  in diluting the meconium, but also in  alleviating 
umbilical cord compression and variable fetal heart decelerations by replacing amniotic fluid volume, 
thereby restoring normal fetal oxygenation. These result would improve Apgar scores, raise umbilical 
artery pH and minimize inutero fetal gasping.
Here intrapartum transcervical amnioinfusion was considered after the detection of meconium 
either  by  spontaneous  rupture  of  membranes  or  by  amniotomy.  The  amnioinfusion  catheter  was 
inserted transvaginally and passed above the baby’s head with one end outside. An intravenous drip 
was connected to this end and normal saline at room temperature was infused. Ideally, 1 litre of normal 
saline should be infused over 30-45 minutes.
In a randomized trial, Wenstrom and Parsons (1989), infused 1000 ml of normal saline through 
an intrauterine catheter into labouring women with fluid meconium and compared the outcomes of 
those women with those who received routine care. The amnioinfusion group experienced a six fold 
decrease in the incidence of meconium visualised below the vocal cords. Similar results have been 
reported by Sadovsky and Coworkers (1989); Macri et al, 1992 Cialone et al., 1994; Eiksen et al.,  
1994. A meta-analysis by Glantz and Hetteney (1996) concluded that amnioinfusion decreased the risk 
of meconium below the vocal cords by 84% Pierce and Colleagues (2000) and Hofmeyr (2001) also 
confirmed this reduction in MAS associated with amnioinfusion (relative risk approximately 0.25). 
Miyazaki  and  Navrez  observed  a  relief  of  variable  decelerations  in  57%  of  patients  receiving 
aminioinfusion as compared to 42% in non infusion group. So, amnioinfusion should be considered 
when thick meconium is noted, especially when FHR monitoring is abnormal. 
APGAR SCORE
Virginia  Apgar  (1953)  developed  the  “APGAR SCORE”  as  a  tool  to  assess  the  need  for 
neonatal resuscitation. It was however designed to give an overview of fetal condition at set times 
following delivery, and to highlight those babies in need of resuscitation, not to define those babies 
with hypoxia. It is affected by other variables such as maternal opiate use, prematurity, aspiration of 
mucoid meconium, cardiac, respiratory, muscle, and CNS problems, and even in the hypoxic newborn 
does not give an indication of the time or duration of insult.
Sign Score0 1 2
Heart rate Absent < 100 > 100
Respiratory effort Absent Slow / irregular Good
Muscle tone Flaccid Some flexion of 
extremities
Active motion
Reflex irritability No response Cry Vigorous cry
Colour Blue / pale Body – pink with 
acrocyanosis
Completely pink
However in the past decade, low Apgar score has been considered as evidence that birth asphyxia has 
occurred  and  was  predictive  of  abnormal  neurological  development  in  the  offspring.  Now  the 
definitions of birth asphyxia used are based on Apgar scores, umbilical cord acid/base status, time to 
spontaneous  breathing,  and  the  neurological/behavioural  condition  of  the  infant.  Using  these 
definitions, the incidence of birth asphyxia lies between 2.9 and 9/1000 deliveries (Levene 1988).
The International classification of disease defines mild asphyxia as,                a 1min Apgar 
score of ≤ 6 and severe asphyxia as a 1 min score of ≤3. However, in term neonates, 1 minute Apgar 
score was more influenced by the mode of delivery and by gestational age rather than by asphyxia. 
Instead 5 minute Apgar score had high concordance with metabolic acidemia. Very low late Apgar 
scores (0-3 at 20 min) were significantly related to mortality during the first year of life(96% in those < 
2.5 kg, 59%  > 2.5 kg). Low Apgar scores were only weakly related to morbidity as 80% of infants 
with a score of <3 at 10, 15 and 20 min that survived were without major handicap. Conversely of 
those babies developing cerebral palsy 55% had scores >7 at 1 min and 73% had >7 at 5 min.
Using a 5 min score of ≤ 7, Ruth and Raivio found the Apgar score to have a sensitivity of 12% 
and a positive predictive value of 19% for abnormal neurodevelopment at 12 months of age (Ruth & 
Raivio/1988).
TERM INTRAUTERINE GROWTH RETARDED BABY

MATERIALS AND METHODS
This prospective study was conducted at  Govt. Hospital  for Women and Children,  Egmore, 
(Institute  of  Obstetrics  and  Gynaecology)  attached  to  Madras  Medical  College  for  a  period  from 
February 2004 to January 2006.
The study group consist of 300 pregnant women selected on the basis of inclusion and exclusion 
criteria.  All of them had meconium stained amniotic fluid of varying degrees. The fetal  heart  rate 
abnormalities  were  recorded  with  intrapartum cardiotocography (Non  –  stress  test).  The  mode  of 
delivery and neonatal outcome were analysed.
  The control group consist of 100 patients in labour with clear liquor. 
STUDY DESIGN 
Prospective Randomised Control Study
INCLUSION CRITERIA
1. Term gestation
2. Singleton pregnancy
3. Cephalic presentation
4. Primi or multigravida
5. With meconium stained amniotic fluid
6. Latent and active stages of labour
7. With or without risk factors (medical illness complicating pregnancy).
8. PROM
EXCLUSION CRITERIA
1. Multiple gestation
2. Malpresentations  
3. Congenital anamolies of the fetus
4. Polyhydramnios
5. Antepartum hemorrhage
6. Preterm pregnancy
STUDY PROTOCOL 
Patients in labour with meconium stained amniotic fluid were selected following the inclusion 
and  exclusion  criteria.  Detailed  history  was  taken  and  patients  were  carefully  examined  for  any 
antepartum or intrapartum risk factors like preeclampsia, IUGR, APH, PROM etc. These patients were 
clinically monitored during labour. The colour of amniotic fluid and degree of meconium was noted at 
the time of amniotomy or spontaneous rupture of membranes and at the time of delivery. The time 
interval  between the detection  of  meconium and the time of  delivery were noted.  Fetal  heart  rate 
abnormalities were recorded using cardiotocograph, after the detection of meconium.
Depending upon the degree of meconium, fetal heart rate abnormalities, stage of labour and 
other risk factors, the time and mode of delivery was decided. After delivery, the immediate fetal well 
being was assessed by Apgar score at 1 min and 5 minutes.
Details  such  as  cord  around the  neck,  meconium staining  of  the  cord,  finger  nails,  vernix 
caseosa, meconium smearing of the body, caput, subgaleal bleed were noted. Weight of the baby taken 
into account. Evidence of IUGR, posmaturity and congenital anamolies were looked for.
After the delivery of placenta, look for its weight, meconium staining, infarcts, calcification etc.
Babies  were  followed  up  in  the  neonatal  period  upto  1  month  using  reply  cards,  for  any 
morbidity and mortality. The morbidity criteria was taken as MAS, chest infections, fever and seizures.
OBSERVATIONS AND RESULTS 
TABLE : 1 
AGE OF PATIENTS
Age (Years) Meconium group Non – meconium group
Number of 
patients
Percentage Number of 
patients
Percentage 
16 – 20 12 4% 6 6%
21 – 25 120 40% 36 36%
26 – 30 120 40% 43 43%
31 – 35 48 16% 15 15%
X2 = 1.2 ; P = 0.76
Majority of the patients were between 21 – 30 years of age in both the groups. In meconium 
group – 80% and in control group 79%.
TABLE 2 
GESTATIONAL AGE
Gestational 
age (wks)
Meconium group Non – meconium group
Number of 
patients
Percentage Number of 
patients
Percentage 
37 – 40 188 62.6% 65 65%
40 – 42 102 34% 34 34%
> 42 W 10 3.3% 1 1%
More than half of the patients were in the gestational age 37 – 40 wks both in study (62.6%) and 
control group (65%).
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TABLE – 3
PARITY OF THE PATIENTS
Gravida Meconium group Non – meconium group
Number of 
patients
Percentage Number of 
patients
Percentage 
Primi 183 61% 48 48%
Multi 117 39% 52 52%
Previous 
uterine scar
31 10.3% 14 14%
X2 = 5.4 ; P = 0.07
In the study group, 61% were primigravida and 39% of the patients were multigravida.
183
48
117
52 31
14
0
50
100
150
200
N
o.
 o
f p
at
ie
nt
s
Primi Multi Previous Uterine scar
PARITY OF THE PATIENTS
Meconium Non-meconium
TABLE – 4
BOOKING OF PATIENTS
Booking of 
Patients
Meconium group Non – meconium group
Number of 
patients
Percentage Number of 
patients
Percentage 
Booked at IOG 159 53% 59 59%
Booked 
outside
126 42% 38 38%
Unbooked 15 5% 3 3%
Total 300 100% 100 100%
X2 = 1.45 ; P = 0.48
Only 5% of the patients were unbooked in the study group.  
TABLE - 5
CLASSIFICATION OF THE PATIENTS WITH RESPECT TO DEGREE OF MECONIUM
Density of meconium Number of patients Percentage
Thin meconium 105 35%
Moderate meconium 43 14.3%
Thick meconium 152 50.7%
Total 300 100%
Nearly half of the patients (50.7%) had thick meconium stained liquor.
DEGREE OF MECONIUM
Thin
35%
Thick
51%
Moderate
14%
TABLE – 6 
Stage of labour when meconium was detected
Stage of labour Number of patients Percentage
Latent phase 177 59%
Active phase 123 41%
Total 300 100%
 In 59% of the patients meconium was detected in the latent phase of labour.
 
STAGE OF LABOUR WHEN MECONIUM WAS DETECTED
Latent phase
59%
Active phase
41%
TABLE -7 
TIME INTERVAL BETWEEN DETECTION OF MECONIUM AND DELIVERY
Density of 
meconium
< 1 hour 1 – 3 hours ≥ 3 hours
Thin MSAF 47 35 23
Moderate MSAF 20 19 4
Thick MSAF 126 24 2
X2 = 57.5 ; P = 0.001
Majority of the cases of meconium stained liquor were delivered within 1 hour of detection of 
meconium.
AMNIOINFUSION:
Amnioinfusion  was  given  for  patients  with  moderate  and  thick  meconium  stained  liquor. 
Among (43 + 154) 195 cases, amnioinfusion was given for 154 cases.
TABLE - 8
NST CHANGES IN MECONIUM GROUP WITH RESPECT TO DEGREE OF MECONIUM
Density of 
meconium
Reactive NST Non reactive NST
Number of 
patients %
Number of 
patients %
Total 
number of 
patients
Thin 
meconium 78 74.28% 27 25.71% 105
Moderate 
meconium 19 44.19% 24 55.81% 43
Thick 
meconium 60 39.47% 92 60.53% 152
Total 157 52.33% 143 47.67% 300
X2 = 31.5 ; P = 0.001
In study group, 52.3% had reactive NST and 47.6% had non – reactive NST. In patients with 
thick meconium stained liquor, 60.53% had non reactive NST. 
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TABLE – 9
NST CHANGES IN NON – MECONIUM GROUP
NST Number of patients Percentage
Reactive NST 86 86%
Non reactive NST 14 14%
14% of the patients had non reactive NST. 
NST CHANGES IN CONTROL GROUP
86%
14%
Reactive NST
Non Reactive NST
TABLE – 10 
MODE OF DELIVERY IN MECONIUM GROUP WITH RESPECT TO DIFFERENT 
DEGREES OF MECONIUM
Density of 
meconium
Labour Natural LSCS Forceps VBAC
Patients % Patients % Patients % Patients %
Total
Thin 
MSAF
65 61.9% 33 31.4% 7 6.6% - - 105
Moderate 
MSAF
13 30.2% 24 55.8% 5 11.6% 1 2.3% 43
Thick 
MSAF
44 28.9% 101 66.4% 3 1.9% 4 2.6% 152
Total 122 40.7% 158 52.7% 15 5% 5 1.7% 300
X2 = 42.3 ; P = 0.001
In study group, 158 patients (52.7%) were delivered by LSCS, of which 101 patients had thick 
meconium stained liquor.
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TABLE - 11
MODE OF DELIVERY IN MECONIUM GROUP WITH RESPECT TO NST
Density of 
meconium NST
Labour Natural LSCS Forceps VBAC
Patients % Patients % Patients % Patients %
Thin 
MSAF
Reactive 52 66 24 30.8 2 2.6 -
Non 
reactive 13 48.2 9 33.3 5 18.5 -
Moderate 
MSAF
Reactive 6 31.6 10 52.6 2 10.5 1 5.3
Non 
reactive 7 29.2 14 58.3 3 12.5 -
Thick 
MSAF
Reactive 15 25 43 71.6 - - 2 3.3
Non 
reactive 29 31.5 58 63 3 3.3 2 2.2
Total 122 158 15 5
In thin meconium group, with reactive NST, 66% delivered vaginally. But in thick meconium group, 
irrespective of the NST, most of them were delivered by LSCS.
TABLE - 12
MODE OF DELIVERY IN NON – MECONIUM GROUP
Mode of delivery Number of patients Percentage
Labour natural 59 59%
LSCS 37 37%
Forceps 4 4%
VBAC - -
In the control group, majority 59% of the patients delivered by  labour natural and 37% 
delivered by LSCS.
MODE OF DELIVERY IN NON-MECONIUM GROUP
59%
37%
4%
Labour Natural
LSCS
Forceps
TABLE - 13
MODE OF DELIVERY IN NON MECONIUM GROUP WITH RESPECT TO NST CHANGES 
NST
Labour Natural LSCS Forceps
Patients % Patients % Patients %
Total
Reactive 54 62.8% 28 32.6% 4 4.65% 86
Non 
Reactive 5 35.7% 9 64.3% - - 14
Total 59 59% 37 37% 4 4% 100
X2 = 5.4; P = 0.07
Among 86 cases of reactive NST, 62.8% of cases delivered by labour natural. Among 14 cases 
of non reactive NST, 64.3% of cases delivered by LSCS.
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TABLE - 14
INDICATIONS FOR CESAREAN SECTION IN STUDY AND CONTROL GROUP
S.No. Indications Study Group Control Group
1. Fetal distress 111 (70.2%) 7 (18.9%)
2. CPD 28 15 
3. CPD with fetal distress 5 -
4. Persistent occipito posterior 1 2
5. Failed induction 3 7
6. Previous LSCS with PROM 6 1
7. Other Causes 4 5
Total No. of Patients 158 37 
Among 158 patients, 31 patients had repeat LSCS in study group. In control group, 14 patients 
had repeat LSCS. The most common indication for LSCS in the study group is fetal distress, 70.2% vs 
18.9% in the control group, Z = 33.4;    P = 0.001; Odds Ratio = 10; 95% CI = 4 – 27. 
TABLE - 15
APGAR SCORE AT 1 MIN IN MECONIUM GROUP WITH RESPECT TO DIFFERENT 
DEGREES OF MECONIUM
1 min 
Apgar
Thin MSAF Moderate MSAF Thick MSAF
Patients % Patients % Patients %
Total
≥ 7/10 71 67.62 23 53.5 60 39.5 154 (51.3%)
5/10, 
6/10 22 20.9 16 37.2 57 37.5 95 (31.7%)
≤ 4/10 12 11.4 4 9.3 35 23.0 51 (17%)
Total 105 43 152 300
X2 = 16.7 ; P = 0.01
Using 1 min Apgar score, only 51.3% of babies had a good Apgar  ≥ 7/10 at 1 min. In thick 
meconium, only 39.5% of babies had Apgar ≥ 7/10 at 1 min, and 23% of babies had a poor Apgar of ≤ 
4/10 at 1 min.
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TABLE - 16
APGAR SCORE AT 5 MINS IN MECONIUM GROUP WITH RESPECT TO DIFFERENT 
DEGREES OF MECONIUM
5 min 
Apgar
Thin MSAF Moderate MSAF Thick MSAF
Patients % Patients % Patients %
Total
≥ 7/10 97 92.4 41 95.4 129 84.9 267 (89%)
5/10, 
6/10 6 5.7 2 4.7 20 13.2 28 (9.3%)
≤ 4/10 2 1.9 - - 3 1.9 5 (1.7%)
Total 105 43 152 300
X2 = 6.3 ; P = 0.18
Using 5 min Apgar score, 89% of the babies had a good Apgar of  ≥ 7/10 at 5 mins. Even in 
patients with thick meconium, 84.9% of babies had a good Apgar of ≥ 7/10 at 5 mins.
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TABLE - 17
RELATIONSHIP BETWEEN DENSITY OF MECONIUM, NST AND APGAR SCORE
Density of 
meconium
≥ 7 /10 5/10, 6/10 ≤ 4/10 Total
Patients % Patients % Patients %
Thin 
MSAF
Reactive 75 96.1% 2 2.6% 1 1.3% 78
Non 
reactive 17 63% 7 26% 3 11% 27
X2= 20.3
P= 0.001
Moderate 
MSAF
Reactive 17 89.5% 2 10.5% - - 19
Non 
reactive 21 87.5% 3 12.5% - - 43
X2= 0.04
P=0.84
Thick 
MSAF
Reactive 57 95% 3 5% - - 60
Non 
reactive 50 54.3% 27 29.3% 15 16.3% 92
X2= 29.2
P= 0.001
Total 237 79% 44 14.6% 19 6.3% 300
With reactive NST, Apgar score is good in all three groups. The incidence of low Apgar is 
higher in those with non – reactive NST. This is satistically significant in thin and thick meconium 
groups.
Table – 18
APGAR SCORE AT 5 MINS IN NON – MECONIUM GROUP WITH RESPECT OF NST
Apgar at 5 min Reactive NST Non reactive NST Total
≥ 7 /10 86 13 99
5/10, 6/10 - 1 1
≤ 4/10 - - -
Total 86 14 100
All patients with reactive NST had a good Apgar of ≥ 7/10 at 5 mins.
 TABLE - 19
APGAR SCORE AT 1 MIN IN NON – MECONIUM GROUP WITH RESPECT TO NST
Apgar at 1  min Reactive NST Non reactive NST Total
≥ 7 /10 67 12 79
5/10, 6/10 19 2 21
≤ 4/10 - - -
About 79% of patients had a good Apgar of ≥ 7/10 at 1 min.
TABLE - 20
BIRTH WEIGHT OF BABIES IN MECONIUM GROUP
Birth weight Thin MSAF Moderate MSAF Thick MSAF Total
1.5 – 1.9 kg 1 - 8 9
2 – 2.4 kg 7 5 24 36
2.5 – 2.9 kg 36 17 47 100
3 – 3.4 kg 41 16 45 102
> 3.5 kg 20 5 28 53
X2 = 13.5;  P = 0.05
TABLE 21
BIRTH WEIGHT OF BABIES IN CONTROL GROUP 
Birth weight No. of Babies
< 2.5 kg 8
2.5 – 2.9 kg 37
3 - 3.5 kg 49
> 3.5 kg 6
Majority of the babies are in the birth weight range 2.5 to 3.5kg in both study and control group. 
Many IUGR babies were noticed with, thick meconium stained liquor.
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TABLE - 22
NICU ADMISSION IN MECONIUM GROUP WITH 
RELATION TO NST 
Density of 
meconium
Reactive NST Non reactive NST
Number of 
patients %
Number of 
patients %
Total 
number of 
patients
Thin MSAF 12 57.1% 10 13.5% 22 23.2
Moderate 
MSAF 2 9.5 8 10.8 10 10.5
Thick 
MSAF 7 33.3 56 75.7 63 66.3
Total 21 100 74 100 95 100
Total number of babies admitted = 95 (31.7%)
Among  157  reactive  NST only  21  (13.4%)  babies  were  admitted.  Among  143  non 
reactive NST, 74 babies (51.8%) were admitted. Majority of the admission is constituted by babies 
from thick meconium group with non – reactive NST (60.9%).
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TABLE 23
REASON FOR NICU ADMISSION IN MECONIUM GROUP
S.No. Reason for Admission Number of babies admitted
1. MAS 25
2. IUGR with MAS 6
3. LGA 5
4. Respiratory distress 33
5. IUGR 12
6. HIE I and II 3
7. Intraventricular hemorrhage 1
8. Subgaleal bleed 1
9. To R/O Sepsis 6
10. IDM 3
Total 95
Percentage of MAS in this study = 10.3%
Among 6 babies which were admitted to TOR/O sepsis, sepsis was present in 3 babies.
TABLE 24
NICU ADMISSION IN CONTROL GROUP
NST Number of babies 
admitted 
Percentage
Reactive 4 4.7%
Non Reactive 1 7.1%
Total 5 5%
Among 86 reactive NST. Only 4.7% babies were admitted. Among 14 non reactive NST, 7.1% 
of babies were admitted.
TABLE 25
REASONS FOR ADMISSION IN CONTROL GROUP
S.No. Reason Number of babies admitted
1. LGA 2
2. IUGR 1
3. IDM 1
4. Perinatal hypoxia 1
(NR NST)
Perinatal mortality was nil with Control Group
TABLE 26
PERINATAL MORTALITY IN THE STUDY GROUP (MECONIUM)
Density of 
Meconium
Reactive NST Non reactive NST Total
Thin MSAF - 3 3
Moderate MSAF - 1 1
Thick MSAF - 6 6
Total 10 (3.3%)
Total number of neonatal deaths – 10 (3.3%). All neonatal deaths occurred in those patients 
with non – reactive NST. In patients with thin meconium stained liquor. 3 babies died – 2 babies died 
due to severe birth asphyxia and hypoxic ischemic encephalopathy stage II and 1 baby died due to 
meconium aspiration syndrome (IUGR). In patients with moderate meconium stained liquor, 1 baby 
died due to  hypoxic ischemic encephalopathy II  (IUGR). In patients  with thick meconium stained 
liquor, 6 babies died. 4 babies died due to meconium aspiration syndrome, 1 baby died due to severe 
birth asphyxia and another one baby died due to bilateral pneumothorax, which developed as a sequelae 
of MAS.
TABLE 27
COMPARISON OF PERINATAL MORTALITY IN STUDY AND CONTROL GROUPS
Study Group Control Group
Total number of patient 300 100
Neonatal deaths 10 0
Percentage 3.3% 0
Z = 1.36;  P = 0.17
TABLE 28
COMPARISON OF PERINATAL MORTALITY WITH RELATION TO NST
Study group Control group
Reactive Non – Reactive Reactive
Non – 
Reactive
Total Number 
of patients 157 143 86 14
Neonatal 0 10 0 0
deaths
Z = 3.02;  P = 0.003 95% CI = 7% (2 – 12%)
The perinatal mortality becomes significant ( P = 0.003) in meconium stained liquor, with non – 
reactive NST.
 
DISCUSSION
This prospective study consists of 300 patients with meconium stained amniotic fluid in labour 
as study group. The control group consists of 100 patients in labour with clear liquor. There were 30 
cases of PIH, 7 cases of GDM and 112 cases of post dated pregnancy in study group. In control group 
there were 10 cases of PIH, 3 cases of GDM, and 35 cases of post dated pregnancy. 
In the study group, 50.7% of patients had thick meconium stained liquor, 14.3% had moderate 
meconium and 35% of patients had thin meconium stained liquor.
In the study group, 47.6% of the patients had non reactive NST vs 14% in the control group, (P 
= 0.001). This shows that the incidence of non – reassuring fetal heart rate pattern was significantly 
higher in women with meconium stained amniotic fluid in labour (47.6% vs 14%).
Similar  observation was made by  Starks et al.,  (1980). They found significantly increased 
incidence of fetal heart rate abnormalities in the meconium group (32.7%) than control (6.1%). 
NON REACTIVE NST IN STUDY AND CONTROL GROUP
Study group Control group
Present study 47.6% 14%
Starks et al (1980) 32.7% 6.1%
The reason for higher fetal heart rate abnormalities in the present study may be explained as 
follows  :  The  criteria  for  FHR  abnormalities  in  the  present  study  are  persistant  tachycardia  / 
bradycardia, absence of variability, repetitive late decelerations, whereas in Starks study, the criteria for 
FHR abnormalities was only late decelerations.
Similar  observations  were  also  made  by  Wong SF,  Chow (2002). They remarked that  the 
incidence of non – reassuring cardiotocography in women presenting with meconium stained amniotic 
fluid was significantly higher (9.8% vs 6.4%).
Depending upon the  density of  meconium,  in  patients  with  thick  meconium stained liquor, 
majority (60.5%) had non – reactive NST and 39.5% had reactive NST. Similar observation was made 
by Halvax et al., (2002) that there is a significant linear association between the thickness of meconium 
and abnormal fetal heart rate pattern during labour.
In the study group, almost half of the patients (52.7%) were delivered by cesarean section as 
compared  to  37%  in  the  control  group.  (52.7%  vs  37%).  This  correlate  closely  with  the  study 
conducted by Faridi, Aggarwal, Delhi (2004) where the incidence of Cesarean section in patients with 
meconium stained liquor is 48%.
CESAREAN SECTION INCIDENCE :
Faridi et al 48%
Present study 52%
    
Similarly, Ziadeh and Sunna (2000) also found that delivery by cesarean section increased by 7 
-14% in patients with meconium stained liquor.
In a  study conducted by  Maymon, Chiam and Furman (1998) in low risk population,  the 
incidence of cesarean section was 5.6% vs 2.3% (P < 0.01).
In this present study, 42% of the patients delivered vaginally, 52.7% of patients were delivered 
by cesarean section and 5% had instrumental delivery (X2 = 42.3, P = 0.001).
The most common indication for cesarean section in the meconium group was fetal distress 
(70.2% vs 18.9% in control group); P = 0.001.
In study group, with reactive NST, 94.9% of babies had good mean Apgar score of ≥ 7/10. But 
with non reactive NST only 61.5% had a good mean Apgar score of  ≥ 7/10.  This shows that the 
incidence of low Apgar score at 1 and 5 minutes in meconium stained amniotic fluid was significantly 
higher when associated with fetal heart rate abnormalities.
A number of investigators have associated low Apgar scores with meconium stained amniotic 
fluids (Starks, 1980; Cole et al, 1985; Ziadeh and Sunna, 2000). In these studies, the incidence of low 
1 and 5 minute Apgar score was approximately two times greater when meconium was present.
Meis and associates (1978) found that heavy meconium increased the risk of low Apgar score, 
MAS and death compared with light meconium. But later on, Bochner and Co authors (1987) reported 
that even with thick meconium, perinatal  morbidity was increased only when non reassuring FHR 
pattern were present.
In the study group, 31.7% of the babies were admitted for NICU care. In patients with reactive 
NST only 13.4% of the babies were admitted, but in those with non – reactive NST 51.8% of babies 
were admitted (P = .0001).
Similarly,  many early reports  have related meconium passage to increased risk of perinatal 
morbidity and mortality, especially when associated with abnormal fetal heart rate patterns. There were 
reports by Fenton and Steer, 1992; Hoble, 1971, Miller et al., 1975; Krebs et al, 1980; Nathan et al,  
1994. 
Ash  AK,  Cambridge  (2000) have  suggested  that  meconium  stained  amniotic  fluids  might 
signify underlying acute  or chronic  fetal  hypoxia with adverse perinatal  outcome,  especially when 
associated with cardiotocographic abnormalities.
The incidence of meconium aspiration syndrome in the study was 9.66%. This corresponds 
closely to the studies conducted by Davis et al., 1985; Falciglia 1988; Rossi et al., 1989; where they 
reported the percentage of MAS developing in infants delivered through meconium stained amniotic 
fluid is 8 – 10%.
In this present study, when MAS incidence is further classified depending upon the density of 
meconium, the MAS incidence in thick meconium stained liquor in 16.4%, in moderate meconium 
stained liquor 2.3% and in thin meconium stained liquor it is 3.8%. This correlates closely with the 
study done by  Rossi and colleagues, 1989, where they reported MAS incidence of 19% in patients 
with thick meconium stained liquor, 5% in patients with moderate meconium stained liquor and 3% in 
patients with thin meconium stained liquor.
Incidence of MAS :
Thin 
Meconium
Moderate 
Meconium
Thick Meconium
Rossi and Colleagues 3% 5% 19%
Present study 3.8% 2.3% 16.4%
The incidence of respiratory complications in our study is high among those group of patients 
with non reactive NST.
Fleischer and colleagues (1992) reported that the risk of neonatal respiratory complications in 
the  presence  of  meconium was  2%,  when  FHR  patterns  were  normal  and  12% when  they  were 
abnormal.
Dellinger et al.,  (2000) retrospectively analysed intrapartum FHR patterns and reported that 
outcomes such as cesarean section low Apgar and admission to the neonatal  intensive care unit in 
patients with meconium stained liquor were significantly related to the FHR pattern.
The perinatal mortality in the study group was 3.3%. There was a total of 10 neonatal deaths. 
This  corresponds  closely  to  the  study conducted  by Zhao  and  Zhang,  China  (2000), where  the 
perinatal mortality was 3.6% (n = 136, 5 neonatal deaths).
Perinatal mortality :  
Zhao and Zhang, China 3.6%
Present study 3.3%
According to  Ziadeh and Sunna (2000) Jordan University, the perinatal mortality increased 
from 2 per 1000 births with clear amniotic fluids to 10 per 1000 with meconium stained amniotic fluids 
P (< 0.001). According to Fraser, Hofmeyr and Alexander (2005), the perinatal mortality was 0.5%.
In this present study, with respect to NST, there was no neonatal deaths in those patients with 
reactive NST and there were 10 neonatal deaths in those with non – reactive NST. (7% vs 0) P = 0.003, 
95% CI = 7% ranging from 2% to 12%. This again indicates that meconium stained amniotic fluid has 
a significant risk of causing perinatal mortality only when it is associated with FHR abnormalities.
Neonatal deaths in the present study : 
Case No 28 : 
25 years old, Selvi, G3P2L2 with 40 weeks gestation (mild preeclampsia) was admitted in active 
labour. ARM was done. Had thick meconium stained liquor with non reactive NST. Amnioinfusion 
was given.  Since estimated  fetal  weight  was  only 1.3kg and patient  was  in  active  labour,  vaginal 
delivery was planned. Patient delivered in 40 minutes by Labour Natural. Baby weighing 1.5kg with 
Apgar 4/10, 7/10. Baby developed MAS and died on 2nd postnatal day.
Case No 30 : 
28 years old, Ammu, G4P3L3 with 40 weeks gestation was admitted in active labour. ARM was 
done. Had thick meconium stained liquor with non reactive NST. Amnioinfusion was given. Patient 
delivered in 25 minutes by labour natural. Admission – delivery interval was 40 mins. Baby weighing 
3.2 kg with Apgar 1/10, 3/10, 4/10 – severe Birth Asphyxia. Baby was connected to ventilator and died 
30 hours after birth.
Case No  40 : 
21 years old, Revathy, a primigravida with 39 weeks gestation was admitted in active labour. 
ARM was done. Had thin meconium stained liquor with non reactive NST. Since she was in active 
labour  with an estimated fetal  weight  of  1.8kg,  vaginal  delivery was planned.  Delivered  by LMC 
forceps in 25 minutes. Baby weighing 2.2 kg with Apgar 3/10, 5/10 – severe birth asphyxia. Baby was 
connected to ventilator and died 48 hours after birth.
Case No 47 :  
26 years old, Dhanalakshmi, G2A1 with 38 weeks gestation was admitted in active labour with 
thin meconium stained liquor  draining PV. NST was non reactive.  Patient  was delivered by LMC 
forceps in 45 minutes. Baby weighing 2.7 kg with Apgar 3/10, 4/10, 5/10- Perinatal hypoxia. Baby 
developed hypoxic ischemic encephalopathy stage II and died 60 hours after birth.
Case No 59 : 
23 years old, Subashini, a primigravida with 40 weeks gestation was admitted in active labour. 
ARM was done. Had moderate meconium stained liquor with non reactive NST. Since the estimated 
fetal weight was 1.6kg, vaginal delivery was planned. She delivered by labour natural in 30 minutes. 
Baby weighing 2 kg with Apgar 3/10, 6/10. Baby developed hypoxic ischemic encephalopathy stage II 
and died 36 hours after birth.
Case No 112 : 
Komala, 25 years old, G2A1 with 40 weeks 5D gestation was admitted in active labour. ARM 
was done. Had clear liquor with non – reactive NST. She delivered by labour natural within 30 minutes 
of detecting non reactive NST. Hindwaters was thin meconium stained. Baby weighing 3.1 kg with 
Apgar 1/10, 3/10, 5/10. Baby developed hypoxic ischemic encephalopathy stage II and died 32 hours 
after birth.
Case No 136 : 
Nirmala, 25 years old primigravida with 39W5D gestation had high fever on admission (Temp 
– 101oF). Patient was in active labour. ARM was done. Had thick meconium stained liquor with non 
reactive NST. Amnioinfusion was given. She delivered in 20 minutes by labour natural. Baby weighing 
3 kg with Apgar 3/10, 5/10, 6/10. Baby developed MAS and died 60 hours after birth.
Case No 152 : 
23  years  old,  Sreedevi,  G2P1L0 with  38  weeks  gestation  was  admitted  with  Jaundice 
complicating pregnancy and she was in active labour with thick meconium stained liquor draining PV. 
NST was non reactive. Amnioinfusion given. She delivered by labour natural in 40 minutes. Baby 
weighing 2.8 kg, with Apgar 3/10, 5/10. Baby developed MAS and died on 3rd postnatal day.
Case No  173 : 
23 years old, Jayalaxmi, G4A3 with 39 weeks 3D gestation was admitted in early labour with 
draining PV. Had thick meconium stained liquor and non reactive NST. Amnioinfusion was given. 
Emergency LSCS was done in 30 minutes. Baby weighing 2 kg with Apgar 2/10, 4/10, 5/10. Baby 
developed MAS and died 48 hours after birth.
Case No 239 : 
24 years old, sangeetha, G2 A1 with 39 weeks gestation was admitted in early labour with thick 
meconium stained liquor draining PV. NST was non reactive. Amnioinfusion  given. Emergency LSCS 
was done within 30 minutes. Baby weighing 2.8 kg with Apgar 4/10, 6/10, 6/10 - severe perinatal 
hypoxia. Baby developed MAS and Bilateral pneumothorax and died on 4th postnatal day.
 
 
    
SUMMARY 
 This  prospective  study was  conducted  to  evaluate  the  perinatal  outcome in  meconium stained 
amniotic fluid. The study group consists of 300 patients in labour with meconium stained amniotic 
fluid. Among these patients, 50.7% had thick meconium stained liquor, 35% of the patients had thin 
meconium stained liquor and 14.3% of the patients had moderate meconium stained liquor. The 
control group consists of 100 patients in labour with clear liquor.
 Meconium stained liquor  was detected in the latent phase in  59% of the patients.  Most of the 
patients (64.3%) in the study group were delivered within 1 hour of detection of meconium. 
 In the study group, 52.3% of patients had reactive NST and 47.6% had non reactive NST. Whereas 
in the control group, 86% of patients had reactive NST and only 14% had non – reactive NST. This 
shows that the incidence of non reassuring cardiotocography is significantly higher in women with 
meconium stained liquor in labour (47.6% vs 14%) P = 0.001.
 In thin meconium group of patients, majority (74.2%) of the patients had reactive NST. Whereas in 
patients  with  thick  meconium stained  liquor,  majority  (60.5%)  had  non  –  reactive  NST.  This 
indicates a significant linear association between the thickness of meconium and abnormal fetal 
heart rate pattern during labour.
 In the study group, almost half of the patients were delivered by cesarean section (52.7% vs 37% in 
the control group) P = 0.001. This higher rate of cesarean section in the meconium group is mainly 
contributed by patients in thick meconium group with non – reactive NST (36.7%). Fetal distress is 
the commonest  indication for  cesarean section in the study group (70.2% vs 18.9% in control 
group) p = 0.001. There was 31 cases of repeat LSCS in the study group and 14 cases of repeat 
LSCS in the control group.
 In the meconium group with reactive NST 94.9% of babies had good mean Apgar score of ≥ 7/10 at 
1 and 5mins. With non – reactive NST, only 61.5% of babies had  good mean Apgar score of  ≥ 
7/10.  In other words,  39.5% of babies had meand Apgar score of < 7/10.  This shows that the 
incidence  of  low  Apgar  score  at  1  and  5  minutes  in  meconium  stained  amniotic  fluid  was 
significantly higher when associated with fetal heart rate abnormalities. 39.5% vs 4.1%.
 In the study group, 31.7% of the babies were admitted for NICU care. In patients with reactive NST 
only 13.4% of the babies were admitted, but in those patients with non – reactive NST 51.8% of the 
babies were admitted to NICU. (51.8% vs 13.4%); P = 0.001. Majority of the NICU admission is 
constituted by babies from thick meconium group with non – reactive NST (58.94%).
 The commonest reason for NICU admission was mild respiratory distress (34.7%). The second 
most common reason was meconium aspiration syndrome (32.6%). The incidence of meconium 
aspiration syndrome in the study group was 10.3%. In the control group, only 5% of the babies 
were admitted. 
 The perinatal mortality in the study group was 3.3% as compared to no neonatal death in the control 
group. (3.3% Vs 0); P = 0.17. There were total of 10 neonatal deaths. 3 babies died in the thin 
meconium  group,  1  baby  died  in  moderate  meconium  group  and  6  babies  died  in  the  thick 
meconium group. All neonatal deaths has occurred in those patients with non reactive NST (7% 
Vs0) P = 0.003, 95% CI = 7%, (2 – 12%).
CONCLUSION
 The incidence  of  non reassuring  fetal  heart  rate  pattern  is  significantly higher  in  women with 
meconium stained amniotic fluid in labour. There is a significant linear association between the 
thickness of meconium and abnormal fetal heart rate pattern during labour.
 The perinatal outcome is good in patients with meconium stained amniotic fluid and reactive NST.
 The cesarean  section  rate,  low Apgar  Score,  neonatal  admissions  and perinatal  mortality were 
significantly higher with meconium stained amniotic fluid and non reactive NST.
So, meconium in the amniotic fluid is associated with obstetric hazard and significantly increased 
risk of adverse neonatal outcomes, only when it is associated with fetal heart rate abnormalities. The 
main clinical value of meconium stained amniotic fluid is to alert the obstetrician to look for further 
signs of fetal compromise.
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PROFORMA
Name : Age: IP No.: Unit:
Address:
Socio economic status: Booked/Unbooked:
Date and Time of Admission:
Initial Admission: ANWard/Labour ward/LW Annex:
Gravida Para Live Abortion LMP
Gestational age: EDD:
Obstetric history: M/H :
History suggestive of PIH/anaemia/heart disease/GDM/Post dated/APH:
Time of onset of labour:
Referred as Meconium stained liquour: Yes/No
General Examination:
Nutrition: Height:
Anemia: Weight:
Pedal edema :
Vital Signs: BP:
PR:
Temp:
CVS:
RS:
Obstetric examination:
P/A: P/V:
 
Any clinical evidence of postdatism/IUGR/Oligohydramnios:
Blood group:
Sonographic findings:
Labour onset:  Spontaneous/Induced (cerviprime/synto)
Syntocinon for acceleration :Given / not given
Any other medicine used:
Duration of labour: Stage I II
Rupture of membranes: Spontaneous/ARM
If ARM, Date and time of ARM:
Colour of liqour:
Quantity of liquor:
Any FHR variation seen, NST:
Amnioinfusion: Given/not given
If meconium stained liqour
Time of detection of meconium, which stage of labour:
Induction - delivery interval:
Time interval between detection of meconium and delivery:
Mode of delivery : Labour Natural
Instrumental
Cesarean
If instrumental, indication:
If cesarean, indication:
Baby: Alive/Dead born
Sex: Male/female
Birth wt:
Apgar : 1 min 5 mins
Placenta at birth : Normal/calcification/ meconium stained/infarcts
Any evidence of IUGR/Postmaturity in the baby :
Other details:
Resuscitation methods:
Meconium at the level of vocal cords: Yes/No
NICU Admission : Yes/No
Reason for Admission: Observation/MAS/Birth asphyxia/
HIE/Respiratory distress/IUGR 
Duration of NICU stay:
Treatment given:
Condition on discharge from PTU:
If died, cause and time of death:
ABREVATIONS
W - Weeks
D - Days
L - Latent Phase
A - Active Phase
R - Reactive Non – Stress Test
NR - Non – Reactive Non Stress Test
FHR - Fetal Heart Rate
LN - Labour Natural
LMC - Low Midcavity forceps
LSCS - Lower Segment Cesarean Section
FD - Fetal Distress
FI - Failed Induction
PROM- Premature rupture of membranes
CPD - Cephalo Pelvic Disproportion.  
POP - Persistent Occipito Posterior
Pl. Previa - Placenta Previa
BOH - Bad Obstetric History 
VBAC - Vaginal Birth After Cesarean Section
NICU - Neonatal Intensive Care Unit
LGA - Large for Gestational Age
IUGR - Intra Uterine growth Retardation 
IVH - Intraventicular Haemorrhage
PIH - Pregnancy Induced Hypertension
GDM - Gestational Diabetes Mellitus
HIE - Hypoxic Ischemic Encephalopathy
R.D. - Respiratory Distress
IDM - Infant of Diabetic Mother
ROP - Right Occipito Posterior
Oligo - Oligohydramnios
B - Booked
UB - Unbooked
 
